Your Location：
Home >
Browse articles >
Jianpi Xiaoai Prescription Ameliorates Chemotherapy Resistance in Colon Cancer by Targeting FGF2 to Inhibit PI3K/Akt Signaling Pathway
Updated：2026-02-28
Previous|Next

    • Jianpi Xiaoai Prescription Ameliorates Chemotherapy Resistance in Colon Cancer by Targeting FGF2 to Inhibit PI3K/Akt Signaling Pathway

      Enhanced Publication
    • JIAN Xiaolan , NING Kangwen , YANG Jiaxiang , KOU Shenglan , KUANG Wanting , WANG Ziqi , TAN Yuqin , ZENG Puhua , TAN Lingjuan , PENG Wei
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 32, Issue 6, Pages: 120-130(2026)

    • DOI： 10.13422/j.cnki.syfjx.20251123     

      CLC：

    • Revised：2025-03-17 ，

      Accepted：18 March 2025 ，

    Scan QR Code

  •  
  •  

  • Full Text(HTML)

  • Figs( 5 ) Tabs( 9 )

  • References

  • Publication Info

  • Metrics

Sections
icon
The trial reading is over, you can activate your VIP account to continue reading.
Deactivate >
icon
The trial reading is over. You can log in to your account, go to the personal center, purchase VIP membership, and read the full text.
Already a VIP member?
Log in >

178

Views

159

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Effect of Jianpi Xiaoai Prescription on Expression of Metastasis-related Factors in Tumor Microenvironment of Nude Mouse Model of Liver Metastasis of Colon Cancer
Effect of Jianpi Xiao' ai Prescription on Akt/mTOR Signaling Pathways in Colorectal Cells
Jianpi Xiao'ai Prescription Inhibits Colorectal Cancer Progression by Inducing Mitochondrial Dysfunction via Modulation of iNOS-ARG1 Axis
Mechanism of Wumeiwan on Inhibiting Fatty Acid Metabolism Reprogramming in Prevention and Treatment of Colorectal Cancer Based on Multi-omics Analysis
Effect and Mechanism of Modified Sini San on Improving Intestinal Mucosal Barrier of Chronic Stress Rats via Regulating Short-chain Fatty Acid Metabolism and Inhibiting HMGB1/RAGE Signaling Pathway

Related Author

HE Weihua
DENG Lan
JIANG Yilan
Xiao-lan JIAN
Pu-hua ZENG
Yong-min LI
Xiao-ning TAN
Feng-jiao HE

Related Institution

Wuhan Hospital of Traditional Chinese Medicine
Affiliated Hospital of Jiangxi University of Chinese Medicine
Affiliated Hospital of Hunan Academy of Chinese Medicine
Innovative Platform of Anti-tumor Chinese Drugs, Hunan Key Laboratory of Chinese Medicine Oncology, The Affiliated Hospital of Hunan Academy of Chinese Medicine
Hunan University of Chinese Medicine， Hunan Provincial Hospital of Integrated Traditional Chinese and Western Medicine